ACRV vs AAPL: Which Stock is Better?
Side-by-side comparison of Acrivon Therapeutics Inc and Apple Inc in 2026
ACRV
Acrivon Therapeutics Inc
$1.96
AAPL
Apple Inc
$245.82
Key Metrics Comparison
| Metric | ACRV | AAPL | Winner |
|---|---|---|---|
| Market Cap | $61.85M | $3.66T | AAPL |
| P/E Ratio | N/A | 33.85 | AAPL |
| EPS (TTM) | $N/A | $7.55 | AAPL |
| Revenue Growth | 0.0% | 6.4% | AAPL |
| Gross Margin | 0.0% | 46.9% | AAPL |
Analyze ACRV
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ACRV or AAPL a better investment?
Comparing ACRV and AAPL: Acrivon Therapeutics Inc has a market cap of $61.85M while Apple Inc has $3.66T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ACRV and AAPL?
ACRV (Acrivon Therapeutics Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ACRV or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ACRV or AAPL?
AAPL has higher revenue growth at 6.4% vs 0.0% for ACRV.
Which company is more profitable: ACRV or AAPL?
Apple Inc (AAPL) has higher gross margins at 46.9% compared to 0.0% for ACRV.
Which is the larger company: ACRV or AAPL?
Apple Inc (AAPL) is larger with a market cap of $3.66T compared to $61.85M for ACRV.
Should I buy ACRV or AAPL in 2026?
Both ACRV and AAPL have investment merit. ACRV trades at $1.96 while AAPL trades at $245.82. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ACRV and AAPL stock?
Key differences: Market Cap ($61.85M vs $3.66T), P/E Ratio (N/A vs 33.8x), Revenue Growth (0.0% vs 6.4%), Gross Margin (0.0% vs 46.9%).